Document
IPR2021-00816, No. 2205-471 Exhibit - Ex 2205 Malackowski Declaration Public Redacted Version (P.T.A.B. Jan. 19, 2022)
Cite Document
IPR2021-00816, No. 2205-471 Exhibit - Ex 2205 Malackowski Declaration Public Redacted Version (P.T.A.B. Jan. 19, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2309-316 Exhibit - Ex 2309 Asbell 2016 (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2309-316 Exhibit - Ex 2309 Asbell 2016 (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2218-259 Exhibit - Ex 2218 Cilurzo Injectability Evaluation 2011 (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2218-259 Exhibit - Ex 2218 Cilurzo Injectability Evaluation 2011 (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2070-201 Exhibit - Exhibit 2070 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
Cite Document
IPR2021-00816, No. 2070-201 Exhibit - Exhibit 2070 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2188-452 Exhibit - Ex 2188 ISO 14161 (P.T.A.B. Jan. 19, 2022)
Cite Document
IPR2021-00816, No. 2188-452 Exhibit - Ex 2188 ISO 14161 (P.T.A.B. Jan. 19, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2274-412 Exhibit - Ex 2274 Roche Finance Report for 2012 Part 1 of 2 (P.T.A.B. Jan. 19, 2022)
Cite Document
IPR2021-00816, No. 2274-412 Exhibit - Ex 2274 Roche Finance Report for 2012 Part 1 of 2 (P.T.A.B. Jan. 19, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2224-267 Exhibit - Ex 2224 DSR5092D PUBLIC REDACTED VERSION (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2224-267 Exhibit - Ex 2224 DSR5092D PUBLIC REDACTED VERSION (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2291-299 Exhibit - Ex 2291 Rosenberg 2006 (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2291-299 Exhibit - Ex 2291 Rosenberg 2006 (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2071-202 Exhibit - Exhibit 2071 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
Cite Document
IPR2021-00816, No. 2071-202 Exhibit - Exhibit 2071 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2087-218 Exhibit - Exhibit 2087 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
Cite Document
IPR2021-00816, No. 2087-218 Exhibit - Exhibit 2087 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
+ More Snippets
Document
IPR2021-00816, No. 1234-626 Exhibit - ���Highlights of Prescribing Information,��� Lucentis, FDA, revised February 2015 (P.T.A.B. Apr. 15, 2022)
Cite Document
IPR2021-00816, No. 1234-626 Exhibit - ���Highlights of Prescribing Information,��� Lucentis, FDA, revised February 2015 (P.T.A.B. Apr. 15, 2022)
+ More Snippets
Document
IPR2021-00816, No. 1015-18 Exhibit - Sandeep Nema John D Ludwig, Pharmaceutical Dosage Forms Parenteral Medications, Volume 1 Formulation and Packaging 3rd ed 2010 ���Nema Vol 1���...
Cite Document
IPR2021-00816, No. 1015-18 Exhibit - Sandeep Nema John D Ludwig, Pharmaceutical Dosage Forms Parenteral Medications, Volume 1 Formulation and Packaging 3rd ed 2010 ���Nema Vol 1���, part 1 (P.T.A.B.
+ More Snippets
Document
IPR2021-00816, No. 1227-609 Exhibit - REG NDNY 00000004 Gilead Sciences Inc Form 10 K 36 (P.T.A.B. Apr. 15, 2022)
Cite Document
IPR2021-00816, No. 1227-609 Exhibit - REG NDNY 00000004 Gilead Sciences Inc Form 10 K 36 (P.T.A.B. Apr. 15, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2054-149 Exhibit - 2054 (P.T.A.B. Jul. 28, 2021)
Cite Document
IPR2021-00816, No. 2054-149 Exhibit - 2054 (P.T.A.B. Jul. 28, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2033-133 Exhibit - 2033 (P.T.A.B. Jul. 28, 2021)
Cite Document
IPR2021-00816, No. 2033-133 Exhibit - 2033 (P.T.A.B. Jul. 28, 2021)
+ More Snippets